Maruti, Reliance, PNB, Sun Pharma, Paytm

0

Here is the list of the top 10 actions likely to be in the spotlight on Monday:

Maruti: Maruti Suzuki India has ruled out returning to the diesel segment because it believes sales of these vehicles will continue to decline with the start of the next phase of emission standards in 2023. India’s largest automaker believes the next phase of Emission standards will increase the costs of diesel vehicles, further impacting their sales in the market which in recent years has seen a gradual shift towards gasoline cars.

RIL: Reliance Industries Ltd (RIL) led by Mukesh Ambani and Saudi Aramco have decided to reassess Aramco’s oil-to-chemical (O2C) investment project in light of the Indian company’s new energy forays. therefore, the request to NCLT to separate O2C activities from RIL is withdrawn. In August 2019, RIL and Saudi Aramco signed a letter of intent so that the latter could potentially acquire a 20% stake in the company headed by Ambani.

Sun Pharmaceuticals: The pharmaceutical company is recalling more than 0.11 million vials of a generic drug used to treat erectile dysfunction in men from the US market due to a manufacturing error. The US branch of Sun Pharma is recalling Tadalafil tablets from the US market, according to the latest application report from the US Food and Drug Administration (FDA).

CGSB: The Petroleum Ministry’s proposal to hand over CGSB’s largest oil and gas fields to foreign companies met strong resistance from the company’s leaders’ union, which said the government should hold the government accountable and give society a level playing field rather than handing over its blue chip assets to the private sector on a plateau. In addition, ONGC will invest up to ??6,000 crore in its ONGC Petro additions Ltd (OPaL) arm to meet capital requirements.

Payment: One97 Communications Ltd., the parent company of Paytm, reported an aggregate gross value of goods (GMV) of ??832 billion (approximately $ 11.2 billion) for October. Global GMV for One97 Communications changed to ??$ 1.956 billion in the quarter ended September 30, an increase of 107% sequentially.

National Bank of Punjab: A vulnerability in the Punjab National Bank (PNB) server would have exposed the personal and financial information of its some 180 million customers for about seven months, according to cybersecurity firm CyberX9. He claimed the vulnerability provided access to the entire PNB digital banking system with administrative control.

Mobile route: Global and domestic investor funds, including Steadview Capital Mauritius, PineBridge Global Fund and Kuber India Fund, have invested ??867.49 crore ($ 116.8 million) through a Qualified Institutional Placement (QIP) in Route Mobile Ltd.

Adani Group: The Adani Group said several containers were seized by customs and Tax Intelligence Directorate (DRI) teams at Mundra Airport on Thursday from a foreign vessel, fearing they contained dangerous goods not declared.

Cadila Health: Pharmaceutical company Zydus Cadila said it has received approval from the US health regulator to market decitabine injection, used to treat certain types of cancer, in the US market. The United States Food and Drug Administration (USFDA) approval was for the injection of decitabine at a dose of 50 mg / vial in a single-dose vial.

FMCG actions: Repeal of India’s three controversial farm laws could impact food companies’ sourcing plans and the recently introduced production-linked incentive program (PLI) in food processing, executives said Of the industry. Last year, when the laws were announced, several food-focused companies said they would make shopping easier and increase productivity while reducing waste and increasing farmers’ incomes.

To subscribe to Mint newsletters

* Enter a valid email address

* Thank you for subscribing to our newsletter.

Never miss a story! Stay connected and informed with Mint. Download our app now !!


Source link

Share.

Comments are closed.